United States Healthcare Equipment & Supplies

Bionano Genomics Inc (BNGO)

Track

Bionano Genomics Inc. has recorded no insider trading activity within the last 90 days. The most recent transactions occurred in mid-2023, when several insiders, including the CEO and CFO, executed buy orders. Prior to this period, the company saw a mix of buying and selling activity by various insiders dating back to 2018.
Ticker: BNGO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Bionano Genomics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 13 Jun 2023
Value US$4,886,959.94 | Price 243.98 | Shares 68,561 (+9.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-14 2023-06-13 B Purchase
0.5
Mamuszka Hannah
Non-Executive Director
68,561 +9.8%
243.98
US$4,886,960 		68,561 +9.8% 243.98 US$4,886,960
2023-05-16 2023-05-16 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
87,608 +41.1%
161.82
US$3,306,575 		87,608 +41.1% 161.82 US$3,306,575
2023-05-16 2023-05-12 B Purchase
1.4
Stewart Christopher P.

Chief Financial Officer

Officer
94,884 +24.2%
260.60
US$2,675,009 		94,884 +24.2% 260.60 US$2,675,009
2022-08-17 2022-08-15 S Sale
3.3
Linney Yvonne
Non-Executive Director
20,000 -100.0%
3.62
US$72,402 		20,000 -100.0% 3.62 US$72,402
2022-05-18 2022-05-16 B Purchase
2.4
BARKER DAVID L
Non-Executive Director
10,000 +256.8%
1.60
US$16,000 		10,000 +256.8% 1.60 US$16,000
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
150 +3.1%
3.98
US$597 		150 +3.1% 3.98 US$597
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
2,675 +121.6%
3.99
US$10,673 		2,675 +121.6% 3.99 US$10,673
2021-12-01 2021-11-29 B Purchase
1.2
Holmlin R. Erik

President and CEO

Executive Director
2,200 +inf%
3.99
US$8,767 		2,200 +inf% 3.99 US$8,767
2018-08-27 2018-08-23 B Purchase TWOMEY CHRISTOPHER J Non-Executive Director
10,000 +inf%
6.13
US$61,250 		10,000 +inf% 6.13 US$61,250
2018-08-27 2018-08-23 B Purchase Domain Partners VIII, L.P. Large shareholder
15,000 +1.6%
6.13
US$91,875 		15,000 +1.6% 6.13 US$91,875
2018-08-27 2018-08-23 B Purchase Holmlin R. Erik

President and CEO

Executive Director
1,630 +inf%
6.13
US$9,984 		1,630 +inf% 6.13 US$9,984
2018-08-27 2018-08-23 B Purchase Borodkin Mark

Chief Operating Officer

Officer
815 +inf%
6.13
US$4,992 		815 +inf% 6.13 US$4,992
2018-10-03 2018-08-21 B Purchase BARKER DAVID L Non-Executive Director
3,894 +inf%
6.47
US$25,194 		3,894 +inf% 6.47 US$25,194
Explore more

More insider trading research around Bionano Genomics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America